1.70
price up icon1.19%   0.02
after-market Handel nachbörslich: 1.66 -0.04 -2.35%
loading
Schlusskurs vom Vortag:
$1.68
Offen:
$1.62
24-Stunden-Volumen:
183.15K
Relative Volume:
0.85
Marktkapitalisierung:
$9.94M
Einnahmen:
$2.35M
Nettoeinkommen (Verlust:
$-2.56M
KGV:
-3.7938
EPS:
-0.4481
Netto-Cashflow:
-
1W Leistung:
-9.09%
1M Leistung:
-7.61%
6M Leistung:
-21.30%
1J Leistung:
-31.17%
1-Tages-Spanne:
Value
$1.60
$1.74
1-Wochen-Bereich:
Value
$1.60
$1.9501
52-Wochen-Spanne:
Value
$1.50
$2.87

Immuron Limited Adr Stock (IMRN) Company Profile

Name
Firmenname
Immuron Limited Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
7
Name
Twitter
@ImmuronLtd
Name
Nächster Verdiensttermin
2024-08-27
Name
Neueste SEC-Einreichungen
Name
IMRN's Discussions on Twitter

Vergleichen Sie IMRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMRN
Immuron Limited Adr
1.70 10.71M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Immuron Limited Adr Aktie (IMRN) Neueste Nachrichten

pulisher
Jul 19, 2025

What drives Immuron Limited Depositary Receipt stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 17, 2025

Immuron - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX - Investing.com

Jun 04, 2025
pulisher
May 30, 2025

Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.

May 30, 2025
pulisher
May 04, 2025

IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan

May 04, 2025
pulisher
Mar 05, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider

Mar 05, 2025
pulisher
Jan 30, 2025

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Jan 30, 2025
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire

Oct 04, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - FinancialContent

Sep 05, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire

Jul 02, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 07, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK

Mar 07, 2024
pulisher
Jul 26, 2022

Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan

Jul 26, 2022
pulisher
Jan 19, 2022

Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq

Jan 19, 2022
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Jun 07, 2018

IMC Reports Rising Revenues & Eyes Colitis Market - Next Investors

Jun 07, 2018
pulisher
Jul 19, 2017

IMC Stock Price and Chart — ASX:IMC - TradingView

Jul 19, 2017

Finanzdaten der Immuron Limited Adr-Aktie (IMRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):